Discovery could increase efficacy of promising cystic fibrosis drug
(Medical Xpress)—A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of Missouri researchers believe they have found ...
Mar 21, 2013
0
0